Dublin, May 02, 2025 (GLOBE NEWSWIRE) -- The "Medical Marijuana - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Medical Marijuana was valued at US$41.3 Billion in 2024 and is projected to reach US$92.4 Billion by 2030, growing at a CAGR of 14.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The report includes the most recent global tariff developments and how they impact the Medical Marijuana market.
What Regulatory and Social Challenges Impact the Medical Marijuana Market?
The medical marijuana market is shaped by a complex regulatory landscape that varies widely between countries and even within states or regions of the same country. While many regions have legalized medical marijuana, the regulatory framework surrounding its cultivation, distribution, and use is often restrictive, requiring rigorous licensing processes, testing, and quality control measures to ensure safety and efficacy.
Additionally, medical marijuana continues to face social stigma, despite growing evidence of its therapeutic benefits. Many patients and healthcare providers are still hesitant to adopt cannabis-based treatments due to concerns about legality, side effects, and the potential for misuse. However, as research continues to support the medical benefits of cannabis, public perception is slowly shifting, and healthcare providers are becoming more open to its integration into patient care plans.
Addressing these regulatory and social challenges is critical to the sustained growth and acceptance of medical marijuana in mainstream healthcare.
Growth in the Medical Marijuana Market Is Driven by Several Factors
The growth in the medical marijuana market is driven by several factors, including the increasing legalization of cannabis for medical purposes in various regions. As more countries and states recognize the therapeutic potential of cannabis, the market expands, driven by increased access to legal products.
Technological advancements in cultivation, extraction, and product formulation have also contributed to market growth, as they lead to higher-quality and more effective medical marijuana products. The rising prevalence of chronic diseases, particularly pain-related conditions, cancer, and neurological disorders, further fuels demand for medical marijuana as an alternative to traditional pharmaceuticals.
Additionally, growing patient awareness and acceptance of cannabis-based treatments, coupled with the diminishing social stigma, are propelling the market forward. Regulatory reforms that streamline the approval and distribution process for medical cannabis products also play a significant role in expanding market opportunities globally, ensuring continued growth and innovation in the medical marijuana sector.
Report Scope
The report analyzes the Medical Marijuana market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.
Segments:
- Type (Extract Form, Dried Flower)
- End-Use (Pain Management, Seizures, Other End-Uses)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Extract Form segment, which is expected to reach US$60.5 Billion by 2030 with a CAGR of a 14.7%. The Dried Flower segment is also set to grow at 13.9% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $11.4 Billion in 2024, and China, forecasted to grow at an impressive 13.6% CAGR to reach $14.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as ABcann Medicinals, Inc., Aphria, Inc., Aurora Cannabis, Inc., Cannabis Sativa Inc., Canopy Growth Corporation and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What's Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 193 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $41.3 Billion |
| Forecasted Market Value (USD) by 2030 | $92.4 Billion |
| Compound Annual Growth Rate | 14.4% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Tariff Impact on Global Supply Chain Patterns
- Medical Marijuana - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Rising Global Legalization Efforts Propel Market Growth for Medical Marijuana
- Increasing Clinical Research Validates Therapeutic Benefits and Spurs Demand
- Expanding Use in Chronic Pain Management Enhances Patient Access to Medical Marijuana
- Technological Innovations in Cultivation and Extraction Methods Drive Product Quality
- Growing Patient Advocacy and Awareness Expand Market Acceptance
- Regulatory Advances in Cannabis Legislation Strengthen Market Opportunities
- Increasing Use in Mental Health Treatment for Disorders Such as PTSD and Anxiety
- Integration of Blockchain for Seed-to-Sale Tracking Boosts Transparency and Compliance
- Rising Demand for Non-smokable Forms Such as Edibles and Oils Expands Consumer Base
- Growing Elderly Population Adopts Medical Marijuana for Age-Related Conditions
FOCUS ON SELECT PLAYERS
- ABcann Medicinals, Inc.
- Aphria, Inc.
- Aurora Cannabis, Inc.
- Cannabis Sativa Inc.
- Canopy Growth Corporation
- Emerald Health Therapeutics Inc.
- Green Relief Inc.
- GW Pharmaceuticals
- Insys Therapeutics, Inc.
- Maricann Group, Inc.
- mCig, Inc.
- Medical Marijuana, Inc.
- The Cronos Group Inc.
- The Supreme Cannabis Company
- Tilray
- United Cannabis
For more information about this report visit https://www.researchandmarkets.com/r/96lztp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
